191 related articles for article (PubMed ID: 35238114)
1. Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis.
Petrelli F; Luciani A; Ghidini A; Cherri S; Gamba P; Maddalo M; Bossi P; Zaniboni A
Head Neck; 2022 May; 44(5):1255-1266. PubMed ID: 35238114
[TBL] [Abstract][Full Text] [Related]
2. De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials.
Patel RR; Ludmir EB; Augustyn A; Zaorsky NG; Lehrer EJ; Ryali R; Trifiletti DM; Adeberg S; Amini A; Verma V
Oral Oncol; 2020 Apr; 103():104608. PubMed ID: 32163853
[TBL] [Abstract][Full Text] [Related]
3. Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.
Rosenberg AJ; Agrawal N; Pearson A; Gooi Z; Blair E; Cursio J; Juloori A; Ginat D; Howard A; Chin J; Kochanny S; Foster C; Cipriani N; Lingen M; Izumchenko E; Seiwert TY; Haraf D; Vokes EE
Oral Oncol; 2021 Nov; 122():105566. PubMed ID: 34662771
[TBL] [Abstract][Full Text] [Related]
4. HPV status and therapeutic initial strategy impact on survival and oncologic outcomes: 5-year results from the multicentric prospective cohort of oropharyngeal cancers Papillophar.
Culié D; Rousseau A; Pretet JL; Lacau Saint Guily J
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3071-3078. PubMed ID: 34661716
[TBL] [Abstract][Full Text] [Related]
5. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy.
Tsai CJ; McBride SM; Riaz N; Kang JJ; Spielsinger DJ; Waldenberg T; Gelblum D; Yu Y; Chen LC; Zakeri K; Wong RJ; Dunn L; Pfister DG; Sherman EJ; Lee NY
JAMA Oncol; 2022 Mar; 8(3):364-372. PubMed ID: 35050342
[TBL] [Abstract][Full Text] [Related]
7. Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
Rosenberg AJ; Izumchenko E; Pearson A; Gooi Z; Blair E; Karrison T; Juloori A; Ginat D; Cipriani N; Lingen M; Sloane H; Edelstein DL; Keyser K; Fredebohm J; Holtrup F; Jones FS; Haraf D; Agrawal N; Vokes EE
BMC Cancer; 2022 Jan; 22(1):17. PubMed ID: 34980038
[TBL] [Abstract][Full Text] [Related]
8. Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for a randomized phase II trial.
Nichols AC; Lang P; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Fung K; de Almeida JR; Bayley A; Goldstein DP; Eskander A; Husain Z; Bahig H; Christopoulous A; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Mendez A; Winquist E; Read N; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Corsten M; Rajaraman M; Johnson-Obaseki S; Eapen L; Odell M; Chandarana S; Banerjee R; Dort J; Matthews TW; Hart R; Kerr P; Dowthwaite S; Gupta M; Zhang H; Wright J; Parker C; Wehrli B; Kwan K; Theurer J; Palma DA
BMC Cancer; 2020 Feb; 20(1):125. PubMed ID: 32059705
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
Moore EJ; Van Abel KM; Routman DM; Lohse CM; Price KAR; Neben-Wittich M; Chintakuntlawar AV; Price DL; Kasperbauer JL; Garcia JJ; Hinni ML; Patel SH; Janus JR; Foote RL; Ma DJ
Head Neck; 2021 Jan; 43(1):229-237. PubMed ID: 32969095
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different treatments for HPV+ oropharyngeal carcinoma: a network meta-analysis.
Petrelli F; Nardone M; Trevisan F; Carioli D; Falasca V; De Stefani A; Capriotti V; Gurizzan C; Lorini L; Berruti A; Luciani A; Bossi P
Eur Arch Otorhinolaryngol; 2023 Mar; 280(3):963-971. PubMed ID: 36261656
[TBL] [Abstract][Full Text] [Related]
11. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy.
Taku N; Wang L; Garden AS; Rosenthal DI; Gunn GB; Morrison WH; Fuller CD; Phan J; Reddy JP; Moreno AC; Spiotto MT; Chronowski G; Shah SJ; Mayo LL; Gross ND; Ferrarotto R; Zhu XR; Zhang X; Frank SJ
Curr Treat Options Oncol; 2021 Jun; 22(6):54. PubMed ID: 34086150
[TBL] [Abstract][Full Text] [Related]
12. Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.
Zeng PYF; Cecchini MJ; Barrett JW; Shammas-Toma M; De Cecco L; Serafini MS; Cavalieri S; Licitra L; Hoebers F; Brakenhoff RH; Leemans CR; Scheckenbach K; Poli T; Wang X; Liu X; Laxague F; Prisman E; Poh C; Bose P; Dort JC; Shaikh MH; Ryan SEB; Dawson A; Khan MI; Howlett CJ; Stecho W; Plantinga P; Daniela da Silva S; Hier M; Khan H; MacNeil D; Mendez A; Yoo J; Fung K; Lang P; Winquist E; Palma DA; Ziai H; Amelio AL; Li SS; Boutros PC; Mymryk JS; Nichols AC
EBioMedicine; 2022 Dec; 86():104373. PubMed ID: 36442320
[TBL] [Abstract][Full Text] [Related]
13. De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.
Masterson L; Moualed D; Liu ZW; Howard JE; Dwivedi RC; Tysome JR; Benson R; Sterling JC; Sudhoff H; Jani P; Goon PK
Eur J Cancer; 2014 Oct; 50(15):2636-48. PubMed ID: 25091798
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus-Negative Oropharyngeal Cancer Survival Outcomes Based on Primary Treatment: National Cancer Database Analysis.
Shama M; Al-Qurayshi Z; Dahl M; Amdur RJ; Bates J; Mendenhall W; Hitchcock K; Festa BM; Ghanem T; Dziegielewski PT
Otolaryngol Head Neck Surg; 2022 Jul; 167(1):100-108. PubMed ID: 34546828
[TBL] [Abstract][Full Text] [Related]
15. De-escalation in HPV-associated oropharyngeal cancer: lessons learned from the past? A critical viewpoint and proposal for future research.
Petar S; Marko S; Ivica L
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4599-4603. PubMed ID: 33599841
[TBL] [Abstract][Full Text] [Related]
16. De-escalation treatment of human papillomavirus-positive oropharyngeal squamous cell carcinoma: an evidence-based review for the locally advanced disease.
Stock GT; Bonadio RRCC; de Castro G
Curr Opin Oncol; 2018 May; 30(3):146-151. PubMed ID: 29474271
[TBL] [Abstract][Full Text] [Related]
17. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
18. Locoregional Recurrence in p16-Positive Oropharyngeal Squamous Cell Carcinoma After TORS.
Carey RM; Brody RM; Shimunov D; Shinn JR; Mady LJ; Rajasekaran K; Cannady SB; Lin A; Lukens JN; Bauml JM; Cohen RB; Basu D; O'Malley BW; Weinstein GS; Newman JG
Laryngoscope; 2021 Dec; 131(12):E2865-E2873. PubMed ID: 34076275
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
20. 'Good cancer gone bad': a narrative review of HPV oropharyngeal cancer and potential poor outcomes.
Alabi O; O'Neill JP
Eur Arch Otorhinolaryngol; 2020 Aug; 277(8):2185-2191. PubMed ID: 32333138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
